PZ Cormay S.A. (CRM) Price & Analysis

2 Followers

CRM Stock Chart & Stats

zł0.55

-zł0.06(-10.36%)

At close: Jul 28 4:00 PM EDT

zł0.55

-zł0.06(-10.36%)

Day’s Range― - ―

52-Week Rangezł0.34 - zł0.89

Previous CloseN/A

Volume94.79K

Average Volume (3M)50.10K

Market Cap

zł46.31M

Enterprise Valuezł59.31

Total Cash (Recent Filing)zł1.70M

Total Debt (Recent Filing)zł11.42M

Price to Earnings (P/E)―

Beta0.17

Next Earnings

Sep 25, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.08

Shares Outstanding84,205,010

10 Day Avg. Volume36,862

30 Day Avg. Volume50,098

Financial Highlights & Ratios

PEG Ratio0.36

Price to Book (P/B)0.69

Price to Sales (P/S)0.33

P/FCF Ratio-14.73

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

CRM FAQ

What was PZ Cormay S.A.’s price range in the past 12 months?

PZ Cormay S.A. lowest stock price was zł0.34 and its highest was zł0.89 in the past 12 months.

What is PZ Cormay S.A.’s market cap?

PZ Cormay S.A.’s market cap is zł46.31M.

When is PZ Cormay S.A.’s upcoming earnings report date?

PZ Cormay S.A.’s upcoming earnings report date is Sep 25, 2026 which is in 58 days.

How were PZ Cormay S.A.’s earnings last quarter?

PZ Cormay S.A. released its earnings results on May 29, 2026. The company reported -zł0.027 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is PZ Cormay S.A. overvalued?

According to Wall Street analysts PZ Cormay S.A.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does PZ Cormay S.A. pay dividends?

PZ Cormay S.A. does not currently pay dividends.

What is PZ Cormay S.A.’s EPS estimate?

PZ Cormay S.A.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does PZ Cormay S.A. have?

PZ Cormay S.A. has 84,205,010 shares outstanding.

What happened to PZ Cormay S.A.’s price movement after its last earnings report?

PZ Cormay S.A. reported an EPS of -zł0.027 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.663%.

Which hedge fund is a major shareholder of PZ Cormay S.A.?

Currently, no hedge funds are holding shares in PL:CRM

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

PZ Cormay S.A.

PZ Cormay S.A., a diagnostic company, provides IVD solutions in Poland and internationally. The company offers analyzers, reagents, cleaning liquids, calibrators, control materials, patterns, and agglutination tests. It also provides analyzers, test strips, inspections, and calibration strips. In addition, the company offers parasitology, such as Paragreen Mini-System, a specialized device for concentrating and preserving stool samples, as well as veterinary medicines. Further, it provides immunochemistry, including SNIBE, MINDRAY, DIESSE, and AliveDX, as well as molecular biology, such as RT-PCR systems, systems for isolating genetic material, workstations, RT-PCR reagent kits, and nucleic acid isolation reagent kits. Additionally, the company offers sampling comprising blood and urine samples and supporting materials, as well as Sentimag systems, Magtrace markers, Magseed Markers, and surgical instruments, as well as HPLC systems, point of care diagnostics, and integrated systems. The company was founded in 1985 and is based in Lomianki, Poland.